Cargando…
Clinical Potential of Targeting Fibroblast Growth Factor‐23 and αKlotho in the Treatment of Uremic Cardiomyopathy
Chronic kidney disease is highly prevalent, affecting 10% to 15% of the adult population worldwide and is associated with increased cardiovascular morbidity and mortality. As chronic kidney disease worsens, a unique cardiovascular phenotype develops characterized by heart muscle disease, increased a...
Autores principales: | Law, Jonathan P., Price, Anna M., Pickup, Luke, Radhakrishnan, Ashwin, Weston, Chris, Jones, Alan M., McGettrick, Helen M., Chua, Winnie, Steeds, Richard P., Fabritz, Larissa, Kirchhof, Paulus, Pavlovic, Davor, Townend, Jonathan N., Ferro, Charles J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7428638/ https://www.ncbi.nlm.nih.gov/pubmed/32212912 http://dx.doi.org/10.1161/JAHA.120.016041 |
Ejemplares similares
-
The RACE-3 is on: double-locking sinus rhythm by upstream and downstream therapy
por: Pavlovic, Davor, et al.
Publicado: (2018) -
Coronary flow velocity reserve and inflammatory markers in living kidney donors
por: Radhakrishnan, Ashwin, et al.
Publicado: (2020) -
Coronary microvascular dysfunction is associated with degree of anaemia in end‐stage renal disease
por: Radhakrishnan, Ashwin, et al.
Publicado: (2021) -
Hypertension and cardiomyopathy associated with chronic kidney disease: epidemiology, pathogenesis and treatment considerations
por: Law, Jonathan P., et al.
Publicado: (2022) -
Coronary microvascular dysfunction: a key step in the development of uraemic cardiomyopathy?
por: Radhakrishnan, Ashwin, et al.
Publicado: (2019)